Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Mariadason

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Oncogene|August 7, 2003
Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturationLeonard Augenlicht, Li Shi, John Mariadason, et al.
Critical Reviews in Oncogenesis|April 5, 2012
Therapeutic targeting of the epidermal growth factor receptor in human cancerNathalie S Dhomen, John Mariadason, Niall Tebbutt, et al.
The Journal of Nutrition|October 28, 2005
Dietary components modify gene expression: implications for carcinogenesisKan Yang, Wancai Yang, John Mariadason, et al.
Clinical Colorectal Cancer|May 30, 2024
BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research PrioritiesOliver Piercey, Jeanne Tie, Frederic Hollande, et al.
The Journal of Nutrition|September 22, 2006
Interaction of genetic and dietary factors in mouse intestinal tumorigenesisLeonard H Augenlicht, Wancai Yang, John Mariadason, et al.
The Journal of Biological Chemistry|September 16, 2003
Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expressionLidija Klampfer, Jie Huang, Georgia Corner, et al.
Cytokine|May 5, 2022
IL-36G promotes cancer-cell intrinsic hallmarks in human gastric cancer cellsNgan Le, Ian Luk, David Chisanga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibitionMiles C Andrews, Andreas Behren, Fiona Chionh, et al.
The American Journal of Pathology|June 27, 2007
c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppressionChang Tong, Zhinan Yin, Zibo Song, et al.
Plos One|August 14, 2008
Meta-analysis of microarray studies reveals a novel hematopoietic progenitor cell signature and demonstrates feasibility of inter-platform data integrationDavendra Sohal, Andrew Yeatts, Kenny Ye, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Oncogene|August 7, 2003
Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturationLeonard Augenlicht, Li Shi, John Mariadason, et al.
Critical Reviews in Oncogenesis|April 5, 2012
Therapeutic targeting of the epidermal growth factor receptor in human cancerNathalie S Dhomen, John Mariadason, Niall Tebbutt, et al.
The Journal of Nutrition|October 28, 2005
Dietary components modify gene expression: implications for carcinogenesisKan Yang, Wancai Yang, John Mariadason, et al.
Clinical Colorectal Cancer|May 30, 2024
BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research PrioritiesOliver Piercey, Jeanne Tie, Frederic Hollande, et al.
The Journal of Nutrition|September 22, 2006
Interaction of genetic and dietary factors in mouse intestinal tumorigenesisLeonard H Augenlicht, Wancai Yang, John Mariadason, et al.
The Journal of Biological Chemistry|September 16, 2003
Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expressionLidija Klampfer, Jie Huang, Georgia Corner, et al.
Cytokine|May 5, 2022
IL-36G promotes cancer-cell intrinsic hallmarks in human gastric cancer cellsNgan Le, Ian Luk, David Chisanga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibitionMiles C Andrews, Andreas Behren, Fiona Chionh, et al.
The American Journal of Pathology|June 27, 2007
c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppressionChang Tong, Zhinan Yin, Zibo Song, et al.
Plos One|August 14, 2008
Meta-analysis of microarray studies reveals a novel hematopoietic progenitor cell signature and demonstrates feasibility of inter-platform data integrationDavendra Sohal, Andrew Yeatts, Kenny Ye, et al.
Pageof 2